Zacks Investment Research on MSN
Ataibeckley completes VLS-01 dosing in Phase IIb depression study
AtaiBeckley ATAI announced the completion of dosing the last patient in the phase IIb Elumina study evaluating VLS-01 for ...
Zacks Investment Research on MSN
TVRD stock rallies 149% so far this week: Here's what you should know
Tvardi Therapeutics TVRD stock has skyrocketed 148.8% so far this week, reflecting strong investor enthusiasm following a ...
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results